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Abstract: Intensive care unit mortality is strongly associated with organ failure rate and severity. The 
sequential organ failure assessment (SOFA) score is assessed to evaluate its efficacy as a diagnostic 
indicator. Statistical analyses investigate the SOFA score distributions in the days leading up to patient 
mortality and patient discharge. It is found that the SOFA score is not an effective predictor of patient 
mortality, but it is a useful tool for prediction of patient discharge from the Intensive Care Unit (ICU). 
The distribution of overall SOFA score was observed not to change notably in the days leading up to 
patient death. However, the SOFA score distribution was observed to have a trend towards lower SOFA 
scores in the days leading up to patient discharge. Finally, assessment of the individual components of 
the overall SOFA score indicated that the coagulation and cardiovascular scores showed the highest 
correlation to mortality and are therefore the most useful individual groups to be used as diagnostic 
indicators. 
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1. INTRODUCTION 
The development of reliable prognostic models is the subject 
of ongoing research in many fields of medicine. Their 
potential and use in clinical management of patients can have 
significant health, social and economic impact (Beck et al. 
2003; Lin et al. 2007; Lilja et al. 2008; Juneja et al. 2011). 
Hence, the search for better, more accurate, and better 
discriminating models that require only the most certain and 
measurable of input data is an ongoing task (Beck et al. 2003; 
Rowan et al. 2007; Minne et al. 2008).  
A primary goal is to ensure these models are adequately 
validated in development. A second major goal in this search 
is to ensure utility of the prognostic model through the need 
for minimal or straightforward input data. In particular, an 
ideal model would require minimal, easily available data that 
had minimal error or variability, while providing a highly 
accurate prediction. 
The use of prognostic models for mortality has a long history 
in critical care.  One main use has looked towards managing 
patient care and treatment decisions (Lilja et al. 2008). A 
greater use has been for delineating and comparing Intensive 
Care Unit (ICU) performance or quality (Timsit et al. 2001; 
Glance et al. 2002; Bakhshi-Raiez et al. 2007). Their use is 
becoming more evident as critical care resources become 
increasingly stressed economically and in terms of nursing or 
clinician time. A good prognostic model could be used to 
better allocate resources in these situations, which would lead 
to more efficient care without reducing outcomes in the 
consistency or quality of care given. 
After the first 2-3 days of patient stay, mortality in the ICU 
and in-hospital are strongly associated with, and/or 
attributable to, organ failure and sepsis (Messahel et al. 1989; 
Tran et al. 1990; Sakr et al. 2008). In particular, a lack of 
organ failure resolution over a patient’s stay is associated 
with increased morbidity and mortality, as commonly 
measured by the sequential organ failure assessment (SOFA) 
score (Vincent et al. 1996; Vincent et al. 1998; Vincent 
2006). However, the specific mechanisms linking organ 
failure to mortality are not necessarily fully understood (Van 
den Berghe 2004; Ellger et al. 2008; Langouche et al. 2008; 
Koch et al. 2009), particularly in terms of the specific 
physiological effects of organ failure leading to mortality. 
That said, it is equally well understood that the cascade of 
stress on major organ and system functions due to organ 
failure leads to increased risk of infection and decreased 
ability to recover, eventually resulting in death (Cryer 2000; 
Jeschke et al. 2004). 
This investigation examines a set of patient data that contains 
two cohorts of patients, with 371 patients (3356 days) on the 
SPRINT tight glycemic control algorithm (August 2005 – 
April 2007) and 413 retrospective patients from 2 years prior 
that pre-dated the introduction of SPRINT (3211 days). The 
data forms the basis of a prior study into the effects of the 
SPRINT protocol. The differences in the two cohorts that 
underwent different glycemic control and the effects on 
mortality are presented in (Chase et al. 2010). In this study, 
SOFA score is assessed as a prognostic indicator and the type 
of glycemic control provided to the patients is not considered. 
Therefore, both patient cohorts are grouped and overall 
conclusions are drawn across the entire 784 patient
  
     
 
2. METHODS 
2.1 SPRINT Glycemic Control Protocol 
SPRINT is a model-derived (Lonergan et al. 2006; Lonergan 
et al. 2006) TGC protocol developed from clinically validated 
computer models used for real-time control in the ICU 
(Chase et al. 2005; Lonergan et al. 2006; Wong et al. 2006). 
Implemented at the Christchurch Hospital Department of 
Intensive Care in August 2005 (Chase et al. 2008), SPRINT 
has been used on over 1,000 patients. In a clinical 
comparison to statistically matched retrospective cohorts, the 
SPRINT TGC intervention reduced hospital mortality for 
those patients staying 3-5 days in the ICU by 25-40% (Chase 
et al. 2008). For the purposes of this investigation, the 
SPRINT and pre-SPRINT cohorts are considered together. It 
is assumed that if patients treated with the SPRINT protocol 
have an improved prognosis, that this will be reflected in 
improved SOFA scores. 
2.2 Patient Data 
This study uses data from 371 patients treated on SPRINT 
(August 2005 – May 2007) and 413 patients from (January 
2003 – August 2005) prior to SPRINT, as in the original 
study. In this study, both cohorts are combined to analyse the 
impact of organ failure and outcome. The Upper South 
Regional Ethics Committee New Zealand granted ethics 
approval for the audit, analysis and publication of this data. 
2.3 Organ Failure Assessment 
Hospital records were examined for all patients and each day 
of ICU stay. The total SOFA score (Vincent et al. 1996; 
Vincent et al. 1998; Moreno et al. 1999) was calculated daily 
for each patient, taking the most abnormal value for each 
parameter in each 24hr period of ICU stay. Where a data 
point was missing or not available for a component, a value 
was interpolated from surrounding data. In this study, the 
Glasgow Coma score reflecting central nervous system 
function was excluded due to its reported lack of robustness 
and unreliability (Hellawell et al. 2000; Udekwu et al. 2004; 
Arts et al. 2005; Kerby et al. 2007; Tallgren et al. 2009), and 
it is thus not consistently recorded in Christchurch Hospital. 
Other studies have made a similar exclusion (Zygun et al. 
2006). The remaining 5 SOFA component scores are each 
directly related to organ function or failure, and thus yield a 
maximum score of 20 (0-4 per metric). The parameters used 
assess: renal, cardiovascular, liver, respiratory function, and 
blood coagulation. A high SOFA score indicates a high level 
of organ dysfunction. Further details are in (Chase et al. 
2010). 
2.4 Analysis and Statistics 
The primary goal of this study is to investigate the SOFA 
score of patients during their stay in the ICU and examine 
whether the SOFA score can be used as a prognostic 
indicator. First, the probability of mortality against SOFA 
score is investigated to determine the overall correlation of 
increasing SOFA score and increase chance of mortality. The 
SOFA score distributions in the days before mortality are 
examined for trends and predictive ability. Conversely, the 
SOFA score distributions in the days leading up to patient 
discharge are also examined to determine if SOFA score is an 
effective tool to identify a positive prognosis. Finally, the 
probability of mortality is examined for individual SOFA 
score components to investigate if specific components are 
better indicators of patient outcome than total SOFA score.  
3. RESULTS 
3.1 Probability of Mortality vs. SOFA Score 
The probability of mortality for different SOFA score ranges 
and for different days in the ICU are presented in Fig. 1. Fig. 
1a presents the analysis for each of the first seven days of 
ICU stay and Fig. 1b presents the same analysis but for three-
day groups. It can be seen in Fig. 1 that the higher SOFA 
score bands are significantly more likely to lead to mortality 
in that given day. Beyond seven days there is a slight decline 
in the probability of death for the higher SOFA score groups. 
While the results in Fig. 1 show a strong correlation between 
SOFA score and mortality, the SOFA bands (0-5, 5-10 and 
10-20) are broad and more detailed analysis is necessary. 
 
a) Probability of death vs. SOFA score range for the 
first seven days of ICU stay. 
 
b) Probability of death vs. SOFA score for 3-day 
groups of ICU stay 
Fig. 1. Probability of death vs. SOFA score. 
3.2 SOFA Score as a Prognostic Indicator 
To assess the SOFA score as a prognostic indicator over the 
course of the patient stay, the SOFA score distribution is 
plotted in the seven days leading up to death. This analysis is 
restricted to the subset of patients that died during their stay 
  
     
 
in the ICU and is presented in Fig. 2. It is evident in Fig. 2 
that there is no clear trend in the SOFA score leading up to 
patient mortality. It might be expected that there would be an 
overall trend towards increasing SOFA score, but this 
behavior is not evident in the results. To provide an 
indication of the statistical significance of any difference in 
the distributions, p-values are calculated using the Wilcoxon 
rank sum and Kolmogorov-Smirnov tests and presented in 
Tables 1 and 2. It is evident that there is little statistically 
significant difference between distributions of SOFA scores 
in the seven days prior to death. 
 
 
 
Fig. 2. SOFA score distributions for patients in the seven 
days leading up to death. 
Table 1.  P-values of distributions in Fig. 2 calculated using 
the Wilcoxon rank sum test for equal medians. 
 
Table 2.  P-values of distributions in Fig. 2 calculated using 
the Kolmogorov-Smirnov test of distribution spread. 
 
Given that SOFA score is a poor indicator of impending 
mortality, SOFA scores are also assessed as an indicator of 
survival in the seven days leading to patient discharge. This 
analysis is presented in Figure 3. It is evident that there are 
much more pronounced trends in the SOFA score 
distributions in the days leading up to patient discharge. 
Specifically, SOFA > 7 decreases significantly, as expected, 
before discharge, and thus SOFA is a more effective indicator 
of positive prognosis than of negative outcomes. Tables 3-4 
present the p-values comparing the distributions in Fig. 3, 
which reflect this outcome. 
 
  
Fig. 3. SOFA score distributions for patients in the seven 
days leading up to discharge from the ICU. 
Table 3.  P-values of the distributions in Fig. 3 calculated 
using the Wilcoxon rank sum test for equal medians. 
 
 
Table 4.  P-values of the distributions in Fig. 3 calculated 
using the two-sample Kolmogorov-Smirnov goodness-of-fit 
hypothesis test. 
 
 
  
     
 
To further investigate SOFA score distribution and assess it 
as a prognostic metric, the odds ratio of death (death / 
discharge) and its inverse, the odds ratio of survival, are 
calculated for each of the 7 days. Results are shown in Fig. 4, 
which is effectively the ratios between Fig. 2 and Fig. 3. 
Fig. 4 shows significant discrimination is achieved between 
the number of patients that are discharged to those that die at 
low SOFA ≤ 4 based on a nominal 4:1 threshold line shown. 
At SOFA ≥ 10 the inverse relation (mortality odds ratio) is 
also significant in its ability to discriminate. Thus, low SOFA 
≤ 4 are a good indicator of patient discharge, and SOFA ≥ 10 
are a good prognostic of impending mortality.  
However, 5 ≤ SOFA ≤ 9 is a critical range of modest organ 
dysfunction in which a majority of initial and maximum 
SOFA scores occur in a medical ICU (Chase et al. 2010). It is 
also a range in which mortality is also potentially quite high, 
as seen in Fig. 2. It is the lack of prognostic ability in this 
range that makes using SOFA score difficult despite its 
obvious potential link to a main cause of ICU mortality. 
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Fig. 4. Ratios of patient numbers that are discharged to 
patients that die (in blue) and the inverse ratio 
(died/discharged) in red. Results are shown for the 7 days 
leading up to the respective patient outcome. 
 
3.3 Individual SOFA score components. 
In all of the previous analyses only the overall aggregate 
SOFA score has been considered. This overall score out of 20 
comprises components that assess renal, cardiovascular, liver, 
and respiratory function, and blood coagulation, each with a 
score of 0-4. To investigate whether any individual 
components may provide improved prognostic capability, the 
probability of death is calculated for each component 
individually. Fig. 5 presents these results. 
 
a) Probability of death vs. respiratory SOFA score 
 
b) Probability of death vs. coagulation SOFA score 
 
c) Probability of death vs. liver/bilirubin SOFA score 
 
d) Probability of death vs. cardiovascular SOFA score 
 
e) Probability of death vs. renal creatinine SOFA score 
Fig. 5. Probability of death vs. individual SOFA score 
component for the first seven days of ICU stay. 
  
     
 
It can be seen in Fig. 5 that the cardiovascular and respiratory 
scores show the strongest correlation with patient mortality 
across the first seven days of ICU stay. The respiratory 
SOFA score also shows a strong correlation between patient 
mortality and increasing score, but does not reach the high 
probability of mortality seen for the cardiovascular and 
coagulation groups, matching clinical observation. There are 
very high mortality percentages (=100%) for the liver-
bilirubin group on days 2 and 3. However, this observation is 
due to very low patient numbers with scores of 3 or 4 in this 
category. The renal creatanine score in Fig. 5e shows some 
unexpected trends with SOFA score. However, this category 
should be used with caution, as the data shows that the 
distribution of SOFA scores within this group tends to be 
very bi-modal. There are very few patients with renal SOFA 
scores of 1 or 2, with most patients having a score of 0, 3 or 
4. The large variation in probabilities seen in Fig. 5e can be 
attributed to these low patient numbers. 
3. DISCUSSION 
The analysis of the SOFA scores of a cohort of 784 medical 
ICU patients has reaffirmed that patient mortality is 
correlated with overall SOFA score. However, there is no 
clear, statistically significant trend observed in the days 
leading to death. It might be expected that the distribution 
moves towards a higher SOFA score in the days leading up to 
mortality, but this trend was not confirmed. This result 
indicates that the SOFA score alone is not a good prognostic 
indicator of negative patient outcome. 
Conversely, if the distribution of SOFA scores is examined in 
the days leading up to patient discharge, a more evident and 
expected downwards trend in SOFA is observed. Analysis of 
p-values for these distributions indicate that this shift in the 
distributions is statistically significant. Therefore, the SOFA 
score can be an effective prognostic tool for positive patient 
outcomes, but not for impending mortality. 
When considering the SOFA score ranges where patient 
outcomes could be predicted, very low total SOFA ≤ 4 are 
likely to lead to patient discharge. Likewise, very high SOFA 
≥ 10 are more likely to lead to death. However, it is the 
middle band that is critical, as these prior outcomes are more 
likely expected, and there is no clear discrimination in this 
range, limiting the use of SOFA as a prognostic marker.  
Finally, individual SOFA cardiovascular and coagulation 
components show strong and reliable trends between 
increasing SOFA score and probability of death. The other 
components were less effective and suffered from low 
numbers despite a large cohort, making further conclusions 
difficult. It is this set of components that may cause the loss 
of clarity in the analysis of total SOFA score. Equally, 
cardiovascular and coagulation components are associated 
with cardiac failure and sepsis, which are leading causes of 
ICU mortality, and may be better prognostic markers. 
Overall, it has been shown that the aggregate SOFA score is 
only effective as an indicator of positive patient outcome if 
the full range of SOFA scores in considered. If the SOFA 
score are grouped into broad bands then there is a strong 
correlation between increasing SOFA score and increased 
chance of patient death. However, these trend are much less 
clear when the full range of SOFA scores are considered. 
4. CONCLUSIONS 
This manuscript presents the evaluation of the SOFA score as 
a prognostic indicator. Overall, SOFA score has limited use 
as an indicator of negative patient outcome, but it is stronger 
as an indicator of positive patient outcomes. More generally, 
organ failure alone is well correlated with mortality but there 
is no specific linkage particularly due to in ability to 
discriminate at intermediate SOFA score values. Hence, 
while organ failure is strongly associated with mortality, 
prognostic capability for a well respected organ failure score 
is minimal in the most clinically useful ranges. 
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